Crossover junction endodeoxyribonuclease (3.1.22.4)

Follow

Industry

CPC
C12Y301/22004

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y301/00Hydrolases acting on ester bonds (3.1)

Current Industry

C12Y301/22004Crossover junction endodeoxyribonuclease (3.1.22.4)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for enzymatic disruption of bacterial biof...
- Patent number 12,161,701
- Issue date Dec 10, 2024
- Research Institute at Nationwide Children's Hospital
- Steven David Goodman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR ENZYMATIC DISRUPTION OF BACTERIAL BIOF...
- Publication number 20210338783
- Publication date Nov 4, 2021
- Research Institute at Nationwide Children's Hospital
- Steven David Goodman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED DCAS9 WITH REDUCED TOXICITY AND ITS USE IN GENETIC CIRCUITS
- Publication number 20210079404
- Publication date Mar 18, 2021
- Massachusetts Institute of Technology
- Christopher A. Voigt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED DCAS9 WITH REDUCED TOXICITY AND ITS USE IN GENETIC CIRCUITS
- Publication number 20200095589
- Publication date Mar 26, 2020
- Massachusetts Institute of Technology
- Christopher A. Voigt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...